We may be another step closer to a vaccine for HIV.
Or not. But the trials of the new mRNA based vaccine that Moderna are developing may begin in just a month’s time.
It uses the technology that has had a massive investment boost thanks to COVID – and which is the basis of several COVID vaccines many people in the UK and around the world have received.
Moderna are looking to recruit 56 people between the ages of 18 and 50 who are currently HIV negative to take part in the trial, with a proposed start date of 19 September 2021, according to a posting on the US government’s Clinical Trials website.
Two mRNA based vaccines will be tried, alone and in combination.
These “phase 1” trial results are expected until May 2023, so (for so many reasons) don’t throw those condoms away just yet.
